Skip to main content
Clinical Trials/NCT05386862
NCT05386862WithdrawnNot Applicable

Wayne Warrior CAnnabis Research and Education: Naturalistic Observation and Harm Reduction

Wayne State University2 sites in 1 countryStarted: July 13, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Withdrawn
Locations
2
Primary Endpoint
Change in Columbia Suicide Severity Rating Scale (C-SSRS)

Study Overview

Brief Summary

This study is looking at therapeutic potential of reducing Tetrahydrocannabinol (THC) levels in regular cannabis smokers using contingency management (CM) intervention in a U.S. veteran population with post-traumatic stress disorder (PTSD).

Detailed Description

In this trial, the investigators will recruit veterans with post-traumatic stress disorder (PTSD) who report using cannabis. Veterans will be assigned (via participant self-selection) into either a naturalistic group that will be followed as the participants continue to use cannabis as they normally do (observation only), or into a "THC (tetrahydrocannabinol) reduction group" in which veterans are asked to switch from their typical cannabis product to using a lower THC/higher Cannabidiol (CBD) product; adherence to this switch will be incentivized using a behavioral intervention called contingency management (CM).

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
19 Years to 69 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • able to provide informed consent, IQ Score >80,
  • served in branch of the US armed forces, report using cannabis,
  • report using cannabis (at least 4x/month)
  • test positive for THC in urine drug screen,
  • meet DSM-5 criteria for PTSD w/ Sx of at least 6 months duration

Exclusion Criteria

  • urine drug screen positive for any other drugs
  • any clinically significant medical problems,
  • any current or past serious psychotic or bipolar disorder diagnosis as determined by SCID-5
  • at immediate high risk for suicide based on the C-SSRS
  • current SUD other than Nicotine Use Disorder, Alcohol (mild or moderate) and Cannabis Use Disorder
  • seeking treatment for Cannabis Use Disorder

Outcomes

Primary Outcomes

Change in Columbia Suicide Severity Rating Scale (C-SSRS)

Time Frame: Baseline, 3, 6, 12 months post baseline

Suicide ideation, intensity, and behavior assessment. This is a clinical interview to assess suicide severity. Reduction in suicide related behaviors represents a better study outcome.

Change in Clinician-Administered PTSD Scale for DSM-5 Total Severity Score (CAPS-5)

Time Frame: Baseline, 3, 6, 12 months post baseline

Assessing change in PTSD symptom severity from baseline, to 3, 6, and 12 months post baseline. A decrease in the CAPS-5 assessment indicates less PTSD symptoms endorsed and a better outcome. Minimum score is 0, maximum score is 20 for PTSD subtotals.

Change in Post-Traumatic Stress Disorder Symptom Checklist for DSM-5 (PCL-5)

Time Frame: Baseline, every 2 weeks for 12 weeks, 3, 6, 12 months post baseline

Assessing change in PTSD symptom and severity over time. This scale is completed by the participants and a lower score indicates less PTSD symptoms and better study outcomes. Maximum score is 80 and minimum score is 20.

Change in Suicide Behavior Questionnaire - Revised (SBQ-R)

Time Frame: Baseline, every 2 weeks for 12 weeks, 3, 6, 12 months post baseline

Suicide ideation, intensity, and behavior assessment completed by participants. Scores range from 3 to 18, with lower score representing better study outcome.

Secondary Outcomes

  • Exploratory analysis of genetic markers associated with endocannabinoid system(Baseline)
  • Change in Beck Depression Inventory-II(Baseline, every 2 weeks for 12 weeks, 3, 6, 12 months post baseline)
  • Change in California Verbal Learning Test(Baseline, 3, 6, 12 months post baseline)
  • Change in Quality of Life Inventory(Baseline, 3, 6, 12 months post baseline)
  • Change in Brief Pain Inventory(Baseline, 3, 6, 12 months post baseline)
  • Change in Iowa Gambling Task(Baseline, 3, 6, 12 months post baseline)
  • Change in State Trait Anxiety Inventory Form Y(Baseline, every 2 weeks for 12 weeks, 3, 6, 12 months post baseline)
  • Change in General Health Survey (Short form 36)(Baseline, 3, 6, 12 months post baseline)
  • Change in Wisconsin Card Sort Task(Baseline, 3, 6, 12 months post baseline)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Leslie Lundahl

Associate Professor

Wayne State University

Study Sites (2)

Loading locations...

Similar Trials

Warrior CARE: Naturalistic Observation and... | Clinical Trial